Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices
Stock Movers3 Helmi

Pfizer 4Q Revenue Beats; Merck’s Forecast Misses Expectations; PepsiCo Pledging to Cut Some Prices

Today's biggest winners and losers in the stock market.


On this episode of Stock Movers:
- Pfizer (PFE) reported revenue for the fourth quarter that beat the average analyst estimate.
- Merck (MRK) forecast 2026 sales and profit that missed Wall Street’s expectations as continued challenges with its HPV vaccine Gardasil, which may remain off the market in China this year, overshadowed growth from newer drugs. Full-year sales will be $65.5 billion to $67 billion, Merck said Tuesday, below the average estimate from analysts. The company expects adjusted earnings of as much as $5.15 a share. The stock fell as much as 3.2% in pre-market trading.
- Snacks and beverage company PepsiCo (PEP) reported better-than-expected fourth-quarter profit, buoyed by strong international demand, and announced a $10 billion share buyback.New York-based PepsiCo, which owns brands such as Lay’s and Gatorade, posted earnings per share of $2.26, slightly ahead of Wall Street estimates.

See omnystudio.com/listener for privacy information.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(2255)

Concentrix Falls, Netgear Rises, Estee Lauder Drops on News of Talks to Buy Puig

Concentrix Falls, Netgear Rises, Estee Lauder Drops on News of Talks to Buy Puig

On this episode of Stock Movers: - Concentrix (CNXC) shares fall as the software company’s second-quarter forecast was weaker than expected. Vital Knowledge also notes “a modest shortfall on FQ1 EPS,”...

24 Maalis 2min

Puig Gains Most Ever; Jefferies' Takeover Talk; Netgear Shares Rise

Puig Gains Most Ever; Jefferies' Takeover Talk; Netgear Shares Rise

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Puig (PUIG SM) shares rise after Estée Lauder said the companies were discussing a deal that would create a c...

24 Maalis 4min

Netgear Shares Rise; Smithfield Foods 4Q Revenue Beats Estimates; AOI Up

Netgear Shares Rise; Smithfield Foods 4Q Revenue Beats Estimates; AOI Up

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Netgear (NTGR) shares rise after the US Federal Communications Commission ordered a ban on the import of new mo...

24 Maalis 3min

Anglo American Down, Exor Slides, Puig Soars

Anglo American Down, Exor Slides, Puig Soars

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Anglo American shares drop as much as 2% amidst a continued correction for precious metals tied to the conflict...

24 Maalis 3min

Estee Lauder Sinks, Norwegian Gains, Flutter Jumps

Estee Lauder Sinks, Norwegian Gains, Flutter Jumps

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Estee Lauder (EL) stocks sank after a report that the company is nearing a deal to acquire Puig Brands, a Spani...

23 Maalis 5min

Closing Bell: Draft Kings, Flutter, Cruise Lines All Jump; Micron Continues to Sink

Closing Bell: Draft Kings, Flutter, Cruise Lines All Jump; Micron Continues to Sink

On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greif...

23 Maalis 4min

Synopsys, Draft Kings Spike; Mastercard Fluctuates

Synopsys, Draft Kings Spike; Mastercard Fluctuates

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Synopsys (SNPS) shares jumped after activist investor Elliott Investment Management made a multibillion-dollar ...

23 Maalis 4min

Apogee Therapeutics Soars, Synopsys Gains, Norwegian Cruise Rises on Decline in Cost of Oil

Apogee Therapeutics Soars, Synopsys Gains, Norwegian Cruise Rises on Decline in Cost of Oil

On this episode of Stock Movers: - Apogee Therapeutics (APGE) soars after the drug developer provided maintenance data from a mid-stage trial that showed its experimental therapy deepened responses in...

23 Maalis 2min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
aikalisa
politiikan-puskaradio
viisupodi
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
tervo-halme
rss-vaalirankkurit-podcast
rss-asiastudio
the-ulkopolitist
rss-podme-livebox
rss-pinnalla
otetaan-yhdet
et-sa-noin-voi-sanoo-esittaa
rss-ulkopoditiikkaa
aihe
rikosmyytit
yksilla-raahessa-podcast
rss-hyvaa-huomenta-bryssel
rss-raha-talous-ja-politiikka